Walgreens' big bet on Europe: Bad idea?
Investors understandably dumped Walgreens' shares over its "new exposure to uncertain European economies," say Timothy W. Martin and Ryan Dezember at The Wall Street Journal. Furthermore, it appears Walgreens overpaid, leading credit-rating agencies to consider downgrading the company. The "once-torrid growth of prescription drugs has slowed in recent years," and Alliance Boots won't help Walgreens reverse its falling sales in the U.S. This could go wrong in many ways.
This topic is deleted.